Role of melatonin in the dynamics of acute spinal cord injury in rats

J Cell Mol Med. 2021 Mar;25(6):2909-2917. doi: 10.1111/jcmm.16325. Epub 2021 Jan 26.

Abstract

Melatonin is well-documented to have the ability of reducing nerve inflammation and scavenging free radicals. However, the therapeutic effect of melatonin on spinal cord injury has not been fully described. In this study, we assessed the effect of melatonin on T9 spinal cord injury established by Allen method in rats. Melatonin deficiency significantly delayed the recovery of sensory and motor functions in SCI rats. Treatment with melatonin significantly alleviated neuronal apoptosis and accelerated the recovery of spinal cord function. These results suggest that melatonin is effective to ameliorate spinal cord injury through inhibition of neuronal apoptosis and promotion of neuronal repair.

Keywords: Luzindole; PI3K-AKT1 pathway; melatonin; spinal cord injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Biomarkers
  • Disease Models, Animal
  • Disease Susceptibility
  • Gene Expression
  • Immunohistochemistry
  • Melatonin / metabolism*
  • Melatonin / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology
  • Nissl Bodies / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Rats
  • Recovery of Function / drug effects
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / etiology*
  • Spinal Cord Injuries / metabolism*
  • Spinal Cord Injuries / pathology

Substances

  • Biomarkers
  • Melatonin